Insights

Cutting-edge AI Drug Discovery PsychoGenics specializes in AI-enabled phenotypic drug discovery, offering a unique opportunity for pharmaceutical companies looking to leverage advanced technology for uncovering new treatments in CNS and orphan disorders.

Partnerships with Industry Leaders The partnership between PsychoGenics and Sunovion Pharmaceuticals to develop an antipsychotic for schizophrenia presents a sales opportunity for collaborating companies looking to access innovative treatment options through established market leaders.

New AI-Enabled Drug Discovery Platform The launch of eCube, a new AI-enabled platform for drug discovery, positions PsychoGenics as a frontrunner in technology-driven research solutions. This presents an opportunity for tech-savvy companies seeking cutting-edge tools for accelerating drug development.

Experienced General Counsel Appointment The hiring of Mark Hofer Esq. as General Counsel showcases PsychoGenics' commitment to legal compliance and strategic decision-making. Companies looking to collaborate with a well-structured organization would find an opportunity in aligning with PsychoGenics under his leadership.

Strong Revenue Potential With reported revenue ranging from $10M to $50M, PsychoGenics presents a lucrative sales opportunity for service providers, vendors, and partners aiming to engage with a financially stable company with significant growth potential in the research services sector.

PsychoGenics Tech Stack

PsychoGenics uses 8 technology products and services including Neat, Slick, Swiper, and more. Explore PsychoGenics's tech stack below.

  • Neat
    Document Management Systems
  • Slick
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • scikit-learn
    Machine Learning
  • Linux
    Programming Languages
  • Google Analytics
    Web Analytics
  • Adobe Fonts
    Web Fonts
  • WP Featherlight
    Web Platform Extensions

Media & News

PsychoGenics's Email Address Formats

PsychoGenics uses at least 1 format(s):
PsychoGenics Email FormatsExamplePercentage
First.Last@psychogenics.comJohn.Doe@psychogenics.com
89%
FLast@psychogenics.comJDoe@psychogenics.com
9%
F_Last@psychogenics.comJ_Doe@psychogenics.com
1%
Last@psychogenics.comDoe@psychogenics.com
1%

Frequently Asked Questions

Where is PsychoGenics's headquarters located?

Minus sign iconPlus sign icon
PsychoGenics's main headquarters is located at 215 College Rd Paramus, New Jersey 07652 US. The company has employees across 3 continents, including North AmericaEuropeOceania.

What is PsychoGenics's official website and social media links?

Minus sign iconPlus sign icon
PsychoGenics's official website is psychogenics.com and has social profiles on LinkedIn.

How much revenue does PsychoGenics generate?

Minus sign iconPlus sign icon
As of June 2025, PsychoGenics's annual revenue reached $15M.

What is PsychoGenics's NAICS code?

Minus sign iconPlus sign icon
PsychoGenics's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does PsychoGenics have currently?

Minus sign iconPlus sign icon
As of June 2025, PsychoGenics has approximately 180 employees across 3 continents, including North AmericaEuropeOceania. Key team members include Chief Technology Officer: D. B.Chief Financial Officer: A. K.Chief Commercial Officer (cco): T. H.. Explore PsychoGenics's employee directory with LeadIQ.

What industry does PsychoGenics belong to?

Minus sign iconPlus sign icon
PsychoGenics operates in the Research Services industry.

What technology does PsychoGenics use?

Minus sign iconPlus sign icon
PsychoGenics's tech stack includes NeatSlickSwiperscikit-learnLinuxGoogle AnalyticsAdobe FontsWP Featherlight.

What is PsychoGenics's email format?

Minus sign iconPlus sign icon
PsychoGenics's email format typically follows the pattern of . Find more PsychoGenics email formats with LeadIQ.

How much funding has PsychoGenics raised to date?

Minus sign iconPlus sign icon
As of June 2025, PsychoGenics has raised $3M in funding. The last funding round occurred on Aug 28, 2024 for $3M.
PsychoGenics

PsychoGenics

Research ServicesNew Jersey, United States51-200 Employees

PsychoGenics is a preclinical CRO with expertise in CNS and orphan disorders. Our mission is to provide the best validated disease models and comprehensive preclinical capabilities to help companies discover the next generation of treatments for severely disabling CNS and orphan disorders, and reduce the attrition rate in clinical development.

We are known for our cutting-edge translational approach to research, our customized solutions, the breadth and quality of our work, as well as for our ability to identify statistically relevant phenotypic changes that help our clients quantify the efficacy of their treatments before they move into the clinic.

With an extensive portfolio of highly predictive disease models and unparalleled experience performing studies for biopharmaceutical companies of all sizes, we enable clients to deliver much needed superior clinical candidates to patients.

Our capabilities include behavioral testing, electrophysiology, translational EEG, quantitative histology, molecular biology, and microdialysis. We offer a variety of validated mouse models including in-licensed transgenic models that support research in areas such as Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, autism spectrum disorders, psychosis and schizophrenia, spinal muscular atrophy, muscular dystrophy and a broad array of pain models.

Section iconCompany Overview

Headquarters
215 College Rd Paramus, New Jersey 07652 US
NAICS Code
5417 - Scientific Research and Development Services
Employees
51-200

Section iconFunding & Financials

  • $3M

    PsychoGenics has raised a total of $3M of funding over 3 rounds. Their latest funding round was raised on Aug 28, 2024 in the amount of $3M.

  • $10M$50M

    PsychoGenics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $3M

    PsychoGenics has raised a total of $3M of funding over 3 rounds. Their latest funding round was raised on Aug 28, 2024 in the amount of $3M.

  • $10M$50M

    PsychoGenics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.